insights_auto
Why is CLLS up 2.86%?
Dive Deeperchevron_right
CLLS:NASDAQ
Cellectis SA
$1.44
arrow_upward
+2.86%(+0.040) 1D
Oct 2, 10:36:03 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CLLS...
Open
$1.45
High
$1.47
Low
$1.43
Mkt. cap
107.53M
Avg. vol.
144.02K
Volume
6.02K
52-wk high
$5.48
52-wk low
$1.25
EPS
-$0.65
Beta
3.00
Shares outstanding
72.09M
No. of employees
227
Open
$1.45
High
$1.47
Low
$1.43
Mkt. cap
107.53M
Avg. vol.
144.02K
Volume
6.02K
52-wk high
$5.48
52-wk low
$1.25
EPS
-$0.65
Beta
3.00
Shares outstanding
72.09M
No. of employees
227
News stories
From web sources and news partners
Stock Titan
·
1 hour ago
Five Singapore clinics focus on foot care; two on women's wellness. Cuprina has agreed to acquire them.
GlobeNewswire
·
1 hour ago
ATA Creativity Global Announces Receipt of a Bid Deficiency Notice from Nasdaq
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA